Task: Answer Verification
Input (English): Question: Do somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation?
Answer: Mutations in TP53, TET2, or DNMT3A identify patients with MDS with shorter OS after HSCT.
Output (English): yes